Since the emergence of oxide thin-film transistors (TFTs) in 2003, i3N has been one of the leading groups in the field. While materials such as indium-gallium-zinc oxide (IGZO) are currently explored at an industrial level, our research group has continuously investigated breakthrough advances in the area.
Harnessing solar energy (perhaps these are the systems that we have been worked on and researched the most. Examples of solar energy conversion technologies are high vacuum tube for hot water, polypropylene collector for hot water, photovoltaic collector to produce electricity for solar streetlamps, electrochemical synthesis of biofuels, among others). So far, European decarbonisation strategies are mainly focused on improving “energy efficiency” (reduce the amount of energy required to provide products and services) and promoting electricity from renewable energy sources, knowing that the major challenge associated with all renewable energy technologies is storage, to fill the gap concerning energy provisions.
The ongoing activity has been centred in developing and processing materials and nanoparticles for: energy, optoelectronic, electronic and bio applications. Work was also done to functionalise interfaces to serve a plethora of applications.
We are witnessing a major investment in preventive medicine and precision medicine with excellent results in increasing longevity, while preserving the quality of life and public health in general.
We are attentive to new approaches for diagnostics, vital signs monitoring and analyses, and therapeutics in clinical and preclinical field. Having the full awareness that our research must be aligned in this direction, as well as with public policies (national, EU and UN objectives), our research fostering the development, beyond the state of the art, of innovative biomedical solutions with high potential for disease prevention, precision medicine and for therapies, with new medical devices, medical imaging systems, functional biomaterials and regenerative medicine. We are witnessing a major investment in preventive medicine and precision medicine with excellent results in increasing longevity, while preserving the quality of life and public health in general.